BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 32375452)

  • 1. [Risk prediction of venous thromboembolism in non-small cell lung cancer patients based on COMPASS-CAT risk assessment model].
    Wang YF; Ma F; Liu BL; Yang K; Li JL; Yu L
    Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):340-345. PubMed ID: 32375452
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.
    Rupa-Matysek J; Lembicz M; Rogowska EK; Gil L; Komarnicki M; Batura-Gabryel H
    Med Oncol; 2018 Apr; 35(5):63. PubMed ID: 29616356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study.
    Abdel-Razeq H; Sharaf B; Al-Jaghbeer MJ; Abu-Fares H; Bater R; Shaer MA; Abu-Jaish H; Laban DA; Salamah O; Tamimi F; Ashouri K; Salameh T; Zughul R; Alhalaseh Y
    J Thromb Thrombolysis; 2023 Oct; 56(3):447-453. PubMed ID: 37430158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model.
    Spyropoulos AC; Eldredge JB; Anand LN; Zhang M; Qiu M; Nourabadi S; Rosenberg DJ
    Oncologist; 2020 Jul; 25(7):e1083-e1090. PubMed ID: 32017293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a nomogram to assess postoperative venous thromboembolism risk in patients with stage IA non-small cell lung cancer.
    Cai Y; Dong H; Li X; Liu Y; Hu B; Li H; Miao J; Chen Q
    Cancer Med; 2023 Jan; 12(2):1217-1227. PubMed ID: 35758614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative venous thromboembolism after surgery for stage IA non-small-cell lung cancer: A single-center, prospective cohort study.
    Dong H; Liang X; Gao Y; Cai Y; Li X; Miao J; Wang W; Hu B; Li H
    Thorac Cancer; 2022 May; 13(9):1258-1266. PubMed ID: 35315227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of D-dimer in non-small cell lung cancer patients receiving radical surgery and its association with postoperative venous thromboembolism.
    Ke L; Cui S; Chen S; Hu B; Li H
    Thorac Cancer; 2020 Sep; 11(9):2483-2492. PubMed ID: 32657038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.
    Gerotziafas GT; Taher A; Abdel-Razeq H; AboElnazar E; Spyropoulos AC; El Shemmari S; Larsen AK; Elalamy I;
    Oncologist; 2017 Oct; 22(10):1222-1231. PubMed ID: 28550032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
    Castellón Rubio VE; Segura PP; Muñoz A; Farré AL; Ruiz LC; Lorente JA
    Thromb Res; 2020 Dec; 196():349-354. PubMed ID: 32977135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation, validation and assessment of a novel nomogram-based risk assessment model for venous thromboembolism in hospitalized patients with lung cancer: A retrospective case control study.
    Li H; Tian Y; Niu H; He L; Cao G; Zhang C; Kaiweisierkezi K; Luo Q
    Front Oncol; 2022; 12():988287. PubMed ID: 36300098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of incidence and risk factors for postoperative venous thromboembolism in patients with stageⅠ a non-small-cell lung cancer].
    Dong HH; Cai YS; Liang XN; Miao JB; Chen QS; Gao YD; Li H
    Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(41):3417-3421. PubMed ID: 34758546
    [No Abstract]   [Full Text] [Related]  

  • 12. The Diagnostic Value of the Systemic Immune-Inflammation Index for Venous Thromboembolism in Lung Cancer Patients: A Retrospective Study.
    Zhang L; Liu X; Yang R; Yang Y; Chen X
    Mediators Inflamm; 2022; 2022():9215311. PubMed ID: 36046761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors of lung cancer complicated with symptomatic venous thromboembolism].
    Gong CY; Li ZW; Zhou DX; Yan H; Bao J; Ye RJ; Cao ZL; Gao ZC; Mu XL
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jun; 39(6):454-8. PubMed ID: 27289575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
    Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
    Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer.
    Lee YG; Kim I; Lee E; Bang SM; Kang CH; Kim YT; Kim HJ; Wu HG; Kim YW; Kim TM; Lee KW; Lee SH; Kim DW; Heo DS
    Thromb Haemost; 2014 Jun; 111(6):1112-20. PubMed ID: 24477503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer.
    Li J; Yi J; Hua L; Su Y; Huo M; Dou F; Zhai Z; Zhu M; Zhang S; Zhang Y
    Thromb Res; 2021 Dec; 208():45-51. PubMed ID: 34695715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism with EGFR monoclonal antibody necitumumab in stage IV non-small cell lung cancer: A retrospective cohort analysis.
    Young K; Paz-Ares L; Thatcher N; Spigel DR; Shahidi J; Soldatenkova V; Grau G; Kurek R; Shepherd FA
    Thromb Res; 2018 Jul; 167():50-56. PubMed ID: 29787943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
    Jianlong M; Diansheng Z; Jing R
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer.
    Li S; Gao P; Qiu J; He X; Mao Y
    J Thromb Thrombolysis; 2021 Oct; 52(3):898-903. PubMed ID: 33599857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
    Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.